Browsing Tag
NTRK-positive tumors
1 post
FDA grants accelerated approval for Bristol Myers Squibb’s Augtyro for NTRK-positive tumors
Bristol Myers Squibb (NYSE: BMY) has received accelerated FDA approval for Augtyro (repotrectinib), a treatment designed for patients…